Results of Effective Treatment of OSA
Cardiovascular Outcomes in Patients Treated for OSA vs. Patients with Untreated OSA
Patients with untreated OSA were 2.68 times more likely to suffer a non-fatal CV event compared to those whose OSA was effectively treated with CPAP, and were 2.5 times more likely to suffer a fatal CV event compared to those whose OSA was effectively treated.
Treatment of OSA Can Positively Impact Hypertension
Reduced daytime blood pressure in patients whose OSA is effectively treated. Effective treatment of OSA resulted in reduced systolic blood pressure in refractory hypertension patients with OSA. Normalized nocturnal blood pressure pattern (restored sipper status) in a non-dipper OSA population whose OSA was effectively treated.
Treatment of OSA Can Positively Impact Heart Failure (HF)
Effective treatment of OSA resulted in improved Left Ventricular Ejection Fraction percent, Left Ventricular End Systolic Diameter and systolic blood pressure in HF patients with OSA. Significantly improved quality of life for HF patients whose OSA was effectively treated.
Treatment of OSA Can Positively Impact Arrhythmias
Appropriate treatment of OSA was associated with reduction in atrial fibrillation recurrence after cardioversion. Untreated OSA is associated with increased rate of recurrence of atrial fibrillation and severity of nocturnal oxygen desaturation.